Does Obesity Influence Body Mass Index Changes in Nulliparous Adolescent Users of Long-Acting Reversible Contraceptives?

Scott, Nadia; Silver, Ellen J.; Dodson, Nancy A.; Coupey, Susan M.

doi:10.1016/j.jpag.2021.08.004

Cited by 4 publications

(4 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Los resultados presentados concuerdan con los reportados en una investigación estadounidense realizada con adolescentes y adultas jóvenes, donde el uso de implantes de ENG no condujo a un aumento significativo de peso e IMC, al compararse con controles que utilizaban otros métodos 22 . Asimismo, otras investigaciones tampoco encontraron cambios en el IMC al comparar el implante de ENG luego de doce meses de uso con el DIU de cobre 23 o con acetato de medroxiprogesterona 24 ; aunque un reciente estudio realizado en adolescentes informaba que el IMC aumentaba a los 6 meses posterior a la inserción del implante, indicativo de ganancia ponderal, siendo el cambio promedio en el IMC significativamente mayor para las usuarias de implante con ENG que para las usuarias de DIU de cobre 25 .…”

Section: Ganancia Ponderal (Kg) Grupounclassified

“…En cuanto a la ganancia ponderal, los resultados de este estudio demuestran que luego de un año de uso del método contraceptivo, el incremento fue significativamente mayor entre las usuarias del DIU de cobre que entre las del implante de ENG; coincidiendo con este hallazgo, un estudio en adolescentes reportó un aumento promedio del IMC de poco menos de dos tercios de 1 kg/m 2 para adolescentes obesas usuarias del DIU, equivalentes a un aumento de peso de 3 libras 25 .…”

Section: Ganancia Ponderal (Kg) Grupounclassified

“…Diversas investigaciones reportan que los métodos hormonales contentivos de solo progestinas se asocian a un aumento de peso en las usuarias, bien sea el AMPD 20,25,28,29,30,31 , el SIU-LNG 32 o los implantes subdérmicos de LNG 31 . Es posible que la ganancia ponderal entre algunas usuarias de implantes sub-dérmicos de ENG se deba a factores genéticos, dado a que se ha reportaron que la variación genética en el gen del receptor de estrógeno 1 (variante ESR1 rs9340799) podría explicar la variabilidad en el aumento de peso entre las usuarias de implantes anticonceptivos de ENG; por tanto, si estos hallazgos se pudiesen replicar con otros medicamentos que contienen progestina, sería posible poder individualizar mejor el asesoramiento y consejería en contracepción 21 .…”

Section: Ganancia Ponderal (Kg) Grupounclassified

See 2 more Smart Citations

Efecto del implante anticonceptivo sub-dérmico de Etonogestrel sobre el peso corporal en mujeres en edad reproductiva

Urdaneta M,

Fernández C,

Baabel-Zambrano

2023

Rev. chil. nutr.

View full text Add to dashboard Cite

Investigación comparativa, con diseño cuasi experimental, de casos y controles, a etiqueta abierta y prospectivo; en la que se propuso comparar el efecto sobre el peso corporal de un implante contraceptivo sub-dérmico liberador de ENG en pacientes de la consulta de planificación familiar ABSTRACT Aim: To analyse the effect on body weight of continuous hormonal contraception by releasing subdermal implant etonogestrel (ENG) in women of reproductive age treated in the family planning consultation of a Venezuelan hospital. Methods: Comparative and applied research, with quasiexperimental, case-control, open label and prospective design, with an intentional sample of 60 women separated to receive the contraceptive implant (Implanon NXT®; cases) or a cooper intrauterine device (IUD) (Cooper T; controls) was carried out. Body weight and body mass index were evaluated before and after 12 months of contraceptive use; as well as demographic characteristics of users, side effects, and contraceptive effectiveness of each method. Results: After one year with the ENG implant, no significant variations were found with respect to initial measurements of body weight (61.21±8.30 vs. 61.23±9.50, p>0.5) and BMI (25.23±3.89 vs 25.26±4.30; p>0.05); on the contrary, to what was observed among IUD users where both body weight and BMI had a significant increase (P<0.05). Likewise, most users remained in the same weight range as when starting the method (p<0.001); while weight gain was greater among IUD users (1,530±2.04 vs. 3,700±3.02; p<0.05). Conclusions: The ENG implant does not produce an increase in body weight after 12 months of use, with minimal adverse effects and high contraceptive efficacy.

show abstract

Section: Ganancia Ponderal (Kg) Grupounclassified

See 1 more Smart Citation

Efecto del implante anticonceptivo sub-dérmico de Etonogestrel sobre el peso corporal en mujeres en edad reproductiva

Urdaneta M,

Fernández C,

Baabel-Zambrano

2023

Rev. chil. nutr.

View full text Add to dashboard Cite

show abstract

“…61 Finally, a retrospective study of adolescents using a wide range of methods found those with obesity who choose a contraceptive implant or levonorgestrel IUD might be prone to weight gain compared with those choosing a copper IUD, but the study is limited as BMI was not always documented at method initiation. 64…”

Section: Contraceptives and Weight Gainmentioning

confidence: 99%

Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence

McNamee

Edelman

et al. 2022

Semin Reprod Med

View full text Add to dashboard Cite

The prevalence of obesity among females of reproductive age is increasing globally. Access to the complete range of appropriate contraceptive options is essential for upholding the reproductive rights of this population group. People with obesity can experience stigma and discrimination when seeking healthcare, and despite limited evidence for provider bias in the context of contraception, awareness for its potential at an individual provider and health systems level is essential. While use of some hormonal contraceptives may be restricted due to increased health risks in people with obesity, some methods provide noncontraceptive benefits including a reduced risk of endometrial cancer and a reduction in heavy menstrual bleeding which are more prevalent among individuals with obesity. In addition to examining systems-based approaches which facilitate the provision of inclusive contraceptive care, including long-acting reversible contraceptives which require procedural considerations, this article reviews current evidence on method-specific advantages and disadvantages for people with obesity to guide practice and policy.

show abstract

Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review

Mooney

Sumithran

2023

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

Does Obesity Influence Body Mass Index Changes in Nulliparous Adolescent Users of Long-Acting Reversible Contraceptives?

Cited by 4 publications

References 29 publications

Efecto del implante anticonceptivo sub-dérmico de Etonogestrel sobre el peso corporal en mujeres en edad reproductiva

Efecto del implante anticonceptivo sub-dérmico de Etonogestrel sobre el peso corporal en mujeres en edad reproductiva

Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence

Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review

Contact Info

Product

Resources

About